Lejoyeux M, Rouillon F
Service de Psychiatrie, Hôpital Bichat-Claude Bernard, Paris.
Encephale. 1996 Dec;22 Spec No 4:40-5.
Suicide provocates 0.5 to 1% of the deaths in France. Suicide appears to be closely related to psychiatric morbidity. History of depression is associated with a 30-fold increase in suicide risk. Globally, the annual incidence of suicide among depressives is 1% and 15% of the depressives die by suicide. When depressive symptoms are retrospectively assessed, it appears that 45 to 70% of patients who committed suicide presented depression. Suicide is the main complication of untreated depression. Patients who commit suicide take the more easily available medications. The decrease in the prescription of barbiturates has been associated with a decrease of the frequency of self-poisoning with barbiturates. In the same time, neuroleptics, antidepressants and benzodiazpines, more often prescribed, induced more lethality by suicide. The number of deaths by millions of prescriptions variates, with the antidepressants, between 13 and 166. They correspond to 0.005% of death each year among patients taking antidepressants. In daily practice, the prescription of antidepressants, which alleviates depressive symptoms, usually prevents suicidal risk among depressives. In some rare cases, antidepressants and other psychoactive agents are used by the patients, in overdosage, to commit suicide. According to the results of all controlled studies of antidepressants, suicide attempts are more frequent among patients taking antidepressants (1.7% of the cases) than among patients receiving placebo (0.8%). These data may be related to methodological bias which are discussed here. They do not initiate to restrain the prescription of antidepressants to depressed patients but to provide more frequent consultations and even to hospitalize depressives at high risk for suicide.
在法国,自杀导致的死亡占比为0.5%至1%。自杀似乎与精神疾病密切相关。抑郁症病史会使自杀风险增加30倍。在全球范围内,抑郁症患者的年自杀发生率为1%,且15%的抑郁症患者死于自杀。当对抑郁症状进行回顾性评估时,似乎45%至70%的自杀患者曾患有抑郁症。自杀是未经治疗的抑郁症的主要并发症。自杀患者会选择更容易获取的药物。巴比妥类药物处方量的减少与巴比妥类药物自我中毒频率的降低相关。与此同时,使用更为频繁的抗精神病药物、抗抑郁药物和苯二氮䓬类药物导致了更高的自杀致死率。每百万张抗抑郁药物处方的死亡人数在13至166人之间变化,这相当于每年服用抗抑郁药物的患者中有0.005%死亡。在日常实践中,缓解抑郁症状的抗抑郁药物处方通常可预防抑郁症患者的自杀风险。在一些罕见情况下,患者会过量服用抗抑郁药物及其他精神活性药物来自杀。根据所有抗抑郁药物对照研究的结果,服用抗抑郁药物的患者(1.7%的病例)比服用安慰剂的患者(0.8%)更频繁地尝试自杀。这些数据可能与本文讨论的方法学偏差有关。它们并非旨在限制对抑郁症患者开具抗抑郁药物,而是为了提供更频繁的咨询,甚至将有高自杀风险的抑郁症患者收治入院。